Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (öffnet neues Fenster)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Quelle‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Indiziert‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (öffnet neues Fenster)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (öffnet neues Fenster)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Quelle‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Indiziert‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (öffnet neues Fenster)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (öffnet neues Fenster)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Quelle‎: Ann Surg 2019;269(5):794-804.

Indiziert‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (öffnet neues Fenster)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (öffnet neues Fenster)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Quelle‎: Spine 2009;34(19):2096-103.

Indiziert‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (öffnet neues Fenster)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (öffnet neues Fenster)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Quelle‎: J Orthop Surg 2017;25(1):2309499016684725.

Indiziert‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (öffnet neues Fenster)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (öffnet neues Fenster)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Quelle‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Indiziert‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (öffnet neues Fenster)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (öffnet neues Fenster)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Quelle‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Indiziert‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (öffnet neues Fenster)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (öffnet neues Fenster)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Quelle‎: J Knee Surg 2017;30(5):460-6.

Indiziert‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (öffnet neues Fenster)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (öffnet neues Fenster)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Quelle‎: J Arthroplasty 2017;32(8):2375-80.

Indiziert‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (öffnet neues Fenster)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (öffnet neues Fenster)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Quelle‎: Am J Orthop 2016;45(7):E439-43.

Indiziert‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (öffnet neues Fenster)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (öffnet neues Fenster)

Dobosz B, Dutka J, Dutka L, Maleta P.

Quelle‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Indiziert‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (öffnet neues Fenster)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (öffnet neues Fenster)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Quelle‎: Spine J 2017;17(7):977-82.

Indiziert‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (öffnet neues Fenster)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (öffnet neues Fenster)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Quelle‎: Orthop Clin North Am 2017;48(2):109-15.

Indiziert‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (öffnet neues Fenster)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (öffnet neues Fenster)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Quelle‎: Ir Med J 2018;111(4):730.

Indiziert‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (öffnet neues Fenster)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (öffnet neues Fenster)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Quelle‎: Anesth Analg 2022;135(3):576-85.

Indiziert‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (öffnet neues Fenster)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (öffnet neues Fenster)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Quelle‎: J Orthop Surg Res 2014;9:50.

Indiziert‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (öffnet neues Fenster)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (öffnet neues Fenster)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Quelle‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Indiziert‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (öffnet neues Fenster)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (öffnet neues Fenster)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Quelle‎: Transfusion 2017;57(2):357-66.

Indiziert‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (öffnet neues Fenster)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (öffnet neues Fenster)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Quelle‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Indiziert‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (öffnet neues Fenster)

Cell saver for adult spinal deformity surgery reduces cost. (öffnet neues Fenster)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Quelle‎: Spine Deform 2017;5(4):272-6.

Indiziert‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (öffnet neues Fenster)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (öffnet neues Fenster)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Quelle‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Indiziert‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (öffnet neues Fenster)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (öffnet neues Fenster)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Quelle‎: Orthopedics 2017;40(6):e1044-9.

Indiziert‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (öffnet neues Fenster)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (öffnet neues Fenster)

Harris RN, Moskal JT, Capps SG.

Quelle‎: J Arthroplasty 2015;30(2):192-5.

Indiziert‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (öffnet neues Fenster)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (öffnet neues Fenster)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Quelle‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indiziert‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (öffnet neues Fenster)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (öffnet neues Fenster)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Quelle‎: Bone Jt Open 2022;3(7):536-42.

Indiziert‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (öffnet neues Fenster)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (öffnet neues Fenster)

Kotzé A, Carter LA, Scally AJ.

Quelle‎: Br J Anaesth 2012;108(6):943-52.

Indiziert‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (öffnet neues Fenster)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (öffnet neues Fenster)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Quelle‎: Transfusion 2017;57(6):1347-58.

Indiziert‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (öffnet neues Fenster)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (öffnet neues Fenster)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Quelle‎: Br J Anaesth 2007;99(6):794-800.

Indiziert‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (öffnet neues Fenster)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (öffnet neues Fenster)

Mehra A, Murray J, DeAlwis C.

Quelle‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Indiziert‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (öffnet neues Fenster)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (öffnet neues Fenster)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Quelle‎: J Arthroplasty 2018;33(6):1705-12.

Indiziert‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (öffnet neues Fenster)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (öffnet neues Fenster)

Moskal JT, Harris RN, Capps SG.

Quelle‎: J Arthroplasty 2015;30(3):365-8.

Indiziert‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (öffnet neues Fenster)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (öffnet neues Fenster)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Quelle‎: Blood Transfus 2013;11(2):260-71.

Indiziert‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (öffnet neues Fenster)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (öffnet neues Fenster)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Quelle‎: Blood Transfus 2014;12(1):40-9.

Indiziert‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (öffnet neues Fenster)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (öffnet neues Fenster)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Quelle‎: Transfusion 2011;51(1):118-24.

Indiziert‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (öffnet neues Fenster)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (öffnet neues Fenster)

Nichols CI, Vose JG.

Quelle‎: J Arthroplasty 2016;31(3):583-589.e1.

Indiziert‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (öffnet neues Fenster)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (öffnet neues Fenster)

Örs Ç, Çaylak R.

Quelle‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Indiziert‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (öffnet neues Fenster)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (öffnet neues Fenster)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Quelle‎: Open Orthop J 2011;5:44-8.

Indiziert‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (öffnet neues Fenster)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (öffnet neues Fenster)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Quelle‎: Anesth Analg 2022;135(3):448-58.

Indiziert‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (öffnet neues Fenster)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (öffnet neues Fenster)

Phan DL, Ani F, Schwarzkopf R.

Quelle‎: J Arthroplasty 2016;31(3):579-82.

Indiziert‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (öffnet neues Fenster)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (öffnet neues Fenster)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Quelle‎: Transfusion 2016;56(2):466-71.

Indiziert‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (öffnet neues Fenster)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (öffnet neues Fenster)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Quelle‎: BMJ 2014;349:g4829.

Indiziert‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (öffnet neues Fenster)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (öffnet neues Fenster)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Quelle‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Indiziert‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (öffnet neues Fenster)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (öffnet neues Fenster)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Quelle‎: J Arthroplasty 2018;33(7):2092-9.e9.

Indiziert‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (öffnet neues Fenster)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (öffnet neues Fenster)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Quelle‎: Transfus Med 2009;19(4):202-6.

Indiziert‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (öffnet neues Fenster)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (öffnet neues Fenster)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Quelle‎: Int Orthop 2019;43(1):39-46.

Indiziert‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (öffnet neues Fenster)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (öffnet neues Fenster)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Quelle‎: Int Orthop 2019;43(12):2707-14.

Indiziert‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (öffnet neues Fenster)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (öffnet neues Fenster)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Quelle‎: J Orthop Surg Res 2011;6:22.

Indiziert‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (öffnet neues Fenster)

Increased hospital costs associated with red blood cell transfusion. (öffnet neues Fenster)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Quelle‎: Transfusion 2015;55(5):1082-9.

Indiziert‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (öffnet neues Fenster)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (öffnet neues Fenster)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Quelle‎: J Arthroplasty 2014;29(8):1512-5.

Indiziert‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (öffnet neues Fenster)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (öffnet neues Fenster)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Quelle‎: J Arthroplasty 2020;35(11):3084-8.

Indiziert‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (öffnet neues Fenster)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (öffnet neues Fenster)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Quelle‎: Thromb Res 2018;171:143-8.

Indiziert‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (öffnet neues Fenster)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (öffnet neues Fenster)

Ye X, Lafuma A, Torreton E, Arnaud A.

Quelle‎: BMC Health Serv Res 2013;13:186.

Indiziert‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (öffnet neues Fenster)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (öffnet neues Fenster)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Quelle‎: Int Orthop 2007;31(3):303-8.

Indiziert‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (öffnet neues Fenster)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (öffnet neues Fenster)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Quelle‎: Medicine 2017;96(52):e9552.

Indiziert‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (öffnet neues Fenster)